Introduction
============

Cancer is a major life-threatening disease worldwide. Approximately 14.1 million patients were newly diagnosed with cancer and 8.2 million people died from cancer in 2012 worldwide \[[@b1-crt-2017-118]\]. The global burden of cancer is expected to grow rapidly due to aging population \[[@b2-crt-2017-118]\].

In Korea, cancer accounts for one in four deaths and more than 200,000 new cancer cases were diagnosed in 2013 \[[@b3-crt-2017-118]\].The number of cancer incidences and deaths are expected to increase with an aging population and westernized lifestyles \[[@b4-crt-2017-118]\]. Additionally, the economic burden of cancer in Korea increased approximately 1.8-fold, from \$11,424 to \$20,858 million, between 2000 and 2010 \[[@b5-crt-2017-118]\].

In this context, cancer statistics are the most important indicator to assess the national cancer burden and form cancer prevention and control strategies. This article aims to provide nationwide cancer statistics including incidence, survival, prevalence, and mortality in 2014.

Materials and Methods
=====================

1. Data sources
---------------

The Korea Central Cancer Registry (KCCR) was established by the Ministry of Health and Welfare in 1980 as a nationwide hospital-based cancer registry. Since 1999, the KCCR has collected cancer incidence data nationwide by integrating a hospital-based KCCR database with data from regional cancer registry programs. The KCCR currently provides the nationwide cancer incidence, survival, and prevalence statistics annually \[[@b6-crt-2017-118]\].

The KCCR built the Korea National Cancer Incidence Database (KNCI DB) from hospitals, 11 population-based registries, and additional medical chart reviews. The KNCI DB contains information regarding age, sex, region, date of diagnosis, primary cancer site, histological type, most valid diagnostic method, and SEER stage. The completeness of cancer incidence data for 2014 was estimated to be 97.8% based on the method proposed by Ajiki et al. \[[@b7-crt-2017-118]\]. The mid-year population and cancer mortality data from 1983 to 2014 were obtained from Statistics Korea \[[@b8-crt-2017-118]\]. To ascertain vital status and to calculate survival and prevalence, the KNCI DB was linked to mortality data and population registration data from Ministry of the Interior.

2. Classification
-----------------

All incidence cases were registered according to the International Classification of Diseases for Oncology, 3rd edition \[[@b9-crt-2017-118]\] and converted to the International Classification of Diseases, 10th edition (ICD-10) \[[@b10-crt-2017-118]\]. The mortality cases were registered according to ICD-10. All cancer cases were reported based on the 24 cancer types.

3. Statistical analyses
-----------------------

Rates were expressed as crude and age-standardized rates (CR and ASR, respectively) per 100,000 individuals. The crude rate was calculated as the total number of incidence/ mortality cases divided by the mid-year population of the specified years. The ASR is a weighted average of the age-specific rates, where the weights are the proportions of persons in the corresponding age groups of a standard population \[[@b11-crt-2017-118]\]. In this report, ASRs were calculated using Segi's world standard population \[[@b12-crt-2017-118]\]. The cumulative risk of developing cancer from birth to life expectancy was calculated using cumulative rates; that is, the sum of the age-specific rates from birth to life expectancy, as follows \[[@b13-crt-2017-118]\].
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Trends in incidence/mortality rates were summarized as an annual percentage change (APC) by using a Joinpoint regression. APC is the average percentage change of rates and is calculated as follows \[[@b11-crt-2017-118]\]:
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, where log(Ry)=b0+b1y,

log(Ry) is the natural log transformed age standardized rates.

y=year, *b*~0~=intercept,*b*~1~=*slope*

The survival duration for each cancer case was determined as the interval between the date of initial diagnosis and the date of death, date of loss of follow-up, or closing date for follow-up. The 5-year relative survival rates were calculated as the ratios of the observed survival of the cancer patients to the expected survival of the general population, which was derived from the standard life table provided by Statistics Korea. Trends in 5-year relative survival rates were evaluated as percentage differences in 5-year relative survival rates from 1993-1995 and 2010-2014. Relative survival rates were calculated using the Ederer II method \[[@b14-crt-2017-118]\] with some minor corrections, based on an algorithm by Paul Dickman \[[@b15-crt-2017-118]\].

Prevalent cases were defined as the number of cancer patients alive on January 1, 2015 among all cancer patients diagnosed between 1999 and 2014. Limited-duration prevalences were calculated using SEER\*Stat software. Any p-values less than 0.05 were considered statistically significant. SEER\*Stat 8.2.1 (National Cancer Institute, Bethesda, MD), Joinpoint 4. 1. 1 (National Cancer Institute), and SAS 9.3 (SAS Institute, Cary, NC) were used in this report.

Selected Findings
=================

1. Incidence
------------

A total of 217,057 cases were newly diagnosed with cancer during the study period ([Table 1](#t1-crt-2017-118){ref-type="table"}). Of these cases, 112,882 (52.0%) were men and 104,175 (48.0%) were women. Thyroid cancer was the most commonly diagnosed cancer in 2014, followed by stomach, colorectal, lung, and breast cancer in 2014. The overall cumulative risk of developing cancer from birth to life expectancy was 36.2%. However, the cumulative risk of developing cancer from birth to life expectancy was higher in men (38.7%) than in women (33.1%) (data not shown).

The total CR and ASR for overall cancer incidences in 2014 were 427.6 and 270.7 per 100,000, respectively ([Table 2](#t2-crt-2017-118){ref-type="table"}). According to sex, CRs for all sites combined were 444.9 per 100,000 in men and 410.3 per 100,000 in women. The ASRs were 302.2 and 255.5 per 100,000 in men and women, respectively. Stomach cancer (CR, 79.2 per 100,000) was the most common cancer in men, followed by lung (CR, 66.0 per 100,000), colorectal (CR, 63.8 per 100,000), liver (CR, 47.5 per 100,000), and prostate cancer (CR, 38.6 per 100,000). These five cancers accounted for 66.3% of newly diagnosed cases in men during the study period. In contrast, thyroid cancer (CR, 97.0 per 100,000) was the most common cancer among women, followed by breast (CR, 72.1 per 100,000), colorectal (CR, 42.5 per 100,000), stomach (CR, 38.5 per 100,000), and lung cancer (CR, 28.7 per 100,000). These five cancers accounted for 67.9% of cases in women.

2. Mortality
------------

In 2014, the total number of deaths from cancer was 76,611, accounting for 28.6% of all deaths ([Table 3](#t3-crt-2017-118){ref-type="table"}). Expressed based on sex, 62.5% and 37.5% of cancer deaths occurred in men and women, respectively ([Table 1](#t1-crt-2017-118){ref-type="table"}).

The total CR and ASR for cancer deaths were 150.9 and 85.1 per 100,000, respectively, in 2014 ([Table 4](#t4-crt-2017-118){ref-type="table"}). The total CR and ASR for cancer deaths per 100,000 were higher among men (CR, 188.7; ASR, 125.8) than in women (CR, 113.2; ASR, 55.6).

According to the cancer sites, lung cancer (CR, 50.4 per 100,000) was the leading cause of death in men, followed by liver (CR, 34.0 per 100,000), stomach (CR, 22.7 per 100,000), colorectal (CR, 18.8 per 100,000), and pancreatic cancer (CR, 10.8 per 100,000). The top five causes of deaths from cancer in women included lung (CR, 18.3 per 100,000), colorectal (CR, 14.1 per 100,000), stomach (CR, 12.4 per 100,000), liver (CR, 11.6 per 100,000), and pancreatic cancer (CR, 9.3 per 100,000).

3. Trends in cancer incidence and mortality
-------------------------------------------

[Fig. 1](#f1-crt-2017-118){ref-type="fig"} shows trends in cancer incidence and mortality from 1983 to 2014. The ASR for all-cancer incidence increased by 3.4% annually from 1999 to 2012, and then began to decrease from 2012 to 2014 (APC, --6.6%) ([Table 5](#t5-crt-2017-118){ref-type="table"}, [Fig. 1](#f1-crt-2017-118){ref-type="fig"}). Cancers in stomach, colorectum, lung and thyroid started to decrease around 2011 ([Table 5](#t5-crt-2017-118){ref-type="table"}, [Fig. 2](#f2-crt-2017-118){ref-type="fig"}). Especially, ASR for thyroid cancer has increased rapidly 22.4% from 1999 to 2011, but then decreased swiftly 10.8% annually starting in 2011. Incidence of breast cancer has increased constantly throughout the period, but APC was slowed from 2005. Conversely, the incidence rates of cervix and liver showed constant decrease for the whole period. The incidence rate for liver cancer has started to decrease since 1999. After 2011, decreasing rate for liver cancer was more steepen.

The ASR for all-cancer mortality rate has been increased until 2002 ([Table 6](#t6-crt-2017-118){ref-type="table"}, [Fig. 1](#f1-crt-2017-118){ref-type="fig"}). After that year, it began to decrease (2002-2014; APC, --2.7%). Same patterns were shown in men and women. Most cancer sites, including lung, liver, colorectum, gallbladder, leukemia, brain and central nervous system, cervix uteri, and thyroid started to decrease in the early 2000s. However, cancers in stomach, larynx, testis, bladder, and non-Hodgkin lymphoma decreased starting in 1999 ([Table 6](#t6-crt-2017-118){ref-type="table"}, [Fig. 3](#f3-crt-2017-118){ref-type="fig"}). Cancers in the pancreas, breast, and prostate showed constant increasing trends for the whole period.

4. Age-specific incidence rates
-------------------------------

Leukemia was the most commonly diagnosed cancer among children between 0 and 14 years of age. Thyroid cancer was the most common cancer among adolescents and young adults between 15 and 34 years of age ([Table 7](#t7-crt-2017-118){ref-type="table"}). For men, the incidence rate of cancer increased until age 70 ([Fig. 4A](#f4-crt-2017-118){ref-type="fig"}). Stomach cancer was the most commonly diagnosed cancer among men 35 to 64 years old, while lung cancer was the most common among men 65 and over. In contrast, thyroid cancer was most commonly diagnosed among women 35 to 64 years old, while colorectal cancer was the most common among women 65 and older. Thyroid and breast cancer showed an inverted U-shaped incidence rates by age ([Fig. 4B](#f4-crt-2017-118){ref-type="fig"}).

5. Survival rates
-----------------

The 5-year relative survival rates for all cancer combined improved remarkably in both sexes, from 41.2% in 1993-1995 to 70.3% in 2010-2014 ([Table 8](#t8-crt-2017-118){ref-type="table"}, [Fig. 5A](#f5-crt-2017-118){ref-type="fig"}). After excluding thyroid cancer, the 5-year relative survival rates for all cancer still increased from 1993 to 2014 ([Fig. 5B](#f5-crt-2017-118){ref-type="fig"}).

The 5-year relative survival rate during 2010-2014 for all cancer combined was 62.2% in men and 78.2% in women, respectively. The 5-year relative survival rate for thyroid cancer was over 100%, while the 5-year relative survival rates for testis, prostate, and breast cancer were over 90% in 2010-2014 for both sexes, respectively. However, the 5-year relative survival rate for pancreatic cancer was only 10.1% in both sexes in 2010-2014.

When compared to the 5-year relative survival rate for men in 1993-1995, prostate cancer diagnosed from 2010 to 2014 showed the most outstanding improvement, followed by stomach cancer, leukemia, lip/oral cavity/pharynx and liver cancer. Among women, stomach cancer diagnosed during 2010-2014 showed the greatest improvement in 5-year relative survival rates compared to those between 1993 and1995, followed by leukemia, non-Hodgkin lymphoma, colorectal, and liver cancer.

6. Prevalence rates
-------------------

A total of 1,464,935 cancer prevalent cases were identified on January 1, 2015 ([Table 1](#t1-crt-2017-118){ref-type="table"}). Of these cases, 645,332 (44.1%) were men and 819,603 (55.9%) were women. The crude and age-standardized prevalence rates for cancer overall were 2,885.8 per 100,000 individuals and 1,837.6 per 100,000 individuals for both sexes, respectively, in 2014 ([Table 9](#t9-crt-2017-118){ref-type="table"}).

The five most common cancers for men were stomach (CR, 615.8 per 100,000), colorectal (CR, 477.1 per 100,000), prostate (CR, 245.3 per 100,000), thyroid (CR, 215.6 per 100,000), and liver cancer (CR, 170.2 per 100,000). In contrast, thyroid cancer was most common in women (CR, 1,076.8 per 100,000), followed by breast (CR, 623.5 per 100,000), colorectal (CR, 320.0 per 100,000), stomach (CR, 310.8 per 100,000), and cervix uteri cancer (CR, 178.0 per 100,000).

Analysis of the period after cancer diagnosis revealed that thyroid (20.1%) cancer was the most prevalent cancer within two years after diagnosis, followed by stomach (14.1%) and colorectal cancer (13.1%) ([Fig. 6](#f6-crt-2017-118){ref-type="fig"}). Thyroid cancer (27.2%) was most prevalent for 2-5 years, followed by stomach (14.8%) and colorectal cancer (13.9%). After 5 years, thyroid cancer (20.4%) was the most prevalent cancer, followed by stomach (18.0%) and colorectal cancer (14.1%).
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###### 

Cancer incidence, deaths, and prevalence by sex in Korea, 2014

  Site/Type                                                    New cases   Deaths    Prevalent cases^[a)](#tfn1-crt-2017-118){ref-type="table-fn"}^                                                    
  ------------------------------------------------------------ ----------- --------- ---------------------------------------------------------------- -------- -------- -------- ----------- --------- ---------
  All sites                                                    217,057     112,882   104,175                                                          76,611   47,869   28,742   1,464,935   645,332   819,603
  Lip, oral cavity, and pharynx                                3,191       2,261     930                                                              1,097    824      273      19,687      13,253    6,434
  Esophagus                                                    2,344       2,131     213                                                              1,540    1,407    133      8,496       7,666     830
  Stomach                                                      29,854      20,087    9,767                                                            8,917    5,767    3,150    235,172     156,264   78,908
  Colon and rectum                                             26,978      16,182    10,796                                                           8,338    4,760    3,578    202,295     121,057   81,238
  Liver                                                        16,178      12,058    4,120                                                            11,566   8,616    2,950    57,691      43,192    14,499
  Gallbladder^[b)](#tfn2-crt-2017-118){ref-type="table-fn"}^   5,576       2,838     2,738                                                            3,931    1,966    1,965    17,061      8,749     8,312
  Pancreas                                                     5,948       3,191     2,757                                                            5,116    2,752    2,364    8,472       4,539     3,933
  Larynx                                                       1,111       1,048     63                                                               410      371      39       9,262       8,714     548
  Lung                                                         24,027      16,750    7,277                                                            17,440   12,785   4,655    63,460      40,098    23,362
  Breast                                                       18,381      77        18,304                                                           2,271    17       2,254    158,916     622       158,294
  Cervix uteri                                                 3,500       \-        3,500                                                            960      \-       960      45,189      \-        45,189
  Corpus uteri                                                 2,214       \-        2,214                                                            264      \-       264      18,381      \-        18,381
  Ovary                                                        2,413       \-        2,413                                                            1,021    \-       1,021    16,161      \-        16,161
  Prostate                                                     9,785       9,785     \-                                                               1,667    1,667    \-       62,256      62,256    \-
  Testis                                                       259         259       \-                                                               14       14       \-       2,570       2,570     \-
  Kidney                                                       4,471       3,108     1,363                                                            944      665      279      31,610      21,404    10,206
  Bladder                                                      3,949       3,182     767                                                              1,354    1,016    338      28,559      23,293    5,266
  Brain and CNS                                                1,725       917       808                                                              1,285    716      569      9,500       4,898     4,602
  Thyroid                                                      30,806      6,174     24,632                                                           346      84       262      328,072     54,696    273,376
  Hodgkin lymphoma                                             278         167       111                                                              70       38       32       2,318       1,471     847
  Non-Hodgkin lymphoma                                         4,948       2,766     2,182                                                            1,574    910      664      31,553      16,984    14,569
  Multiple myeloma                                             1,396       758       638                                                              864      473      391      4,811       2,513     2,298
  Leukemia                                                     3,080       1,771     1,309                                                            1,671    921      750      17,151      9,534     7,617
  Other and ill-defined                                        14,645      7,372     7,273                                                            3,951    2,100    1,851    86,292      41,559    44,733

CNS, central nervous system.

Limited-duration prevalent cases on January 1, 2015. These are patients who were diagnosed between January 1, 1999 and December 31, 2014 and who were alive on January 1, 2015. Multiple primary cancer cases were counted multiple times,

Includes the gallbladder and other/unspecified parts of the biliary tract.

###### 

Crude and age-standardized cancer incidence rates by sex in Korea, 2014

  Site/Type                                                    Crude incidence rate per 100,000   Age-standardized incidence rate per 100,000^[a)](#tfn3-crt-2017-118){ref-type="table-fn"}^                           
  ------------------------------------------------------------ ---------------------------------- -------------------------------------------------------------------------------------------- ------- ------- ------- -------
  All sites                                                    427.6                              444.9                                                                                        410.3   270.7   302.2   255.5
  Lip, oral cavity, and pharynx                                6.3                                8.9                                                                                          3.7     4.0     6.1     2.3
  Esophagus                                                    4.6                                8.4                                                                                          0.8     2.8     5.5     0.4
  Stomach                                                      58.8                               79.2                                                                                         38.5    35.8    52.7    21.4
  Colon and rectum                                             53.1                               63.8                                                                                         42.5    31.9    42.6    23.0
  Liver                                                        31.9                               47.5                                                                                         16.2    19.4    31.4    8.6
  Gallbladder^[b)](#tfn4-crt-2017-118){ref-type="table-fn"}^   11.0                               11.2                                                                                         10.8    6.2     7.4     5.2
  Pancreas                                                     11.7                               12.6                                                                                         10.9    6.7     8.4     5.4
  Larynx                                                       2.2                                4.1                                                                                          0.2     1.3     2.7     0.1
  Lung                                                         47.3                               66.0                                                                                         28.7    27.2    43.7    14.9
  Breast                                                       36.2                               0.3                                                                                          72.1    24.0    0.2     47.7
  Cervix uteri                                                 6.9                                \-                                                                                           13.8    4.6     \-      9.0
  Corpus uteri                                                 4.4                                \-                                                                                           8.7     2.9     \-      5.7
  Ovary                                                        4.8                                \-                                                                                           9.5     3.3     \-      6.4
  Prostate                                                     19.3                               38.6                                                                                         \-      11.2    25.6    \-
  Testis                                                       0.5                                1.0                                                                                          \-      0.5     1.0     \-
  Kidney                                                       8.8                                12.2                                                                                         5.4     5.7     8.4     3.3
  Bladder                                                      7.8                                12.5                                                                                         3.0     4.5     8.4     1.5
  Brain and CNS                                                3.4                                3.6                                                                                          3.2     2.7     3.0     2.4
  Thyroid                                                      60.7                               24.3                                                                                         97.0    43.3    17.3    69.8
  Hodgkin lymphoma                                             0.5                                0.7                                                                                          0.4     0.5     0.5     0.4
  Non-Hodgkin lymphoma                                         9.7                                10.9                                                                                         8.6     6.8     8.1     5.7
  Multiple myeloma                                             2.8                                3.0                                                                                          2.5     1.6     2.0     1.3
  Leukemia                                                     6.1                                7.0                                                                                          5.2     5.2     6.1     4.3
  Other and ill-defined                                        28.8                               29.1                                                                                         28.6    18.6    21.0    16.6

CNS, central nervous system.

Age-adjusted using the Segi's world standard population,

Includes the gallbladder and other/unspecified parts of the biliary tract.

###### 

The top 10 leading causes of death in Korea, 2014

  Rank   Cause of death                       No. of deaths   Percentage of all deaths   Age-standardized death rate per 100,000^[a)](#tfn5-crt-2017-118){ref-type="table-fn"}^
  ------ ------------------------------------ --------------- -------------------------- ----------------------------------------------------------------------------------------
         All causes                           267,692         100.0                      295.7
  1      Cancer                               76,611          28.6                       85.1
  2      Heart disease                        26,588          9.9                        27.7
  3      Cerebrovascular disease              24,486          9.1                        24.8
  4      Intentional self-harm (suicide)      13,836          5.2                        19.3
  5      Pneumonia                            12,021          4.5                        11.6
  6      Diabetes mellitus                    10,526          3.9                        10.7
  7      Chronic lower respiratory diseases   7,171           2.7                        6.9
  8      Disease of liver                     6,635           2.5                        8.0
  9      Transport accidents                  5,700           2.1                        8.0
  10     Hypertensive diseases                5,061           1.9                        4.9
         Others                               79,057          29.5                       88.8

Source: Mortality Data, 2014, Statistics Korea \[[@b8-crt-2017-118]\].

Age-adjusted using the Segi's world standard population.

###### 

Crude and age-standardized cancer mortality rates by sex in Korea, 2014

  Site/Type                                                    Crude mortality rate per 100,000   Age-standardized mortality rate per 100,000^[a)](#tfn6-crt-2017-118){ref-type="table-fn"}^                          
  ------------------------------------------------------------ ---------------------------------- -------------------------------------------------------------------------------------------- ------- ------ ------- ------
  All sites                                                    150.9                              188.7                                                                                        113.2   85.1   125.8   55.6
  Lip, oral cavity, and pharynx                                2.2                                3.2                                                                                          1.1     1.3    2.1     0.5
  Esophagus                                                    3.0                                5.5                                                                                          0.5     1.7    3.6     0.2
  Stomach                                                      17.6                               22.7                                                                                         12.4    9.7    15.1    5.7
  Colon and rectum                                             16.4                               18.8                                                                                         14.1    9.0    12.6    6.3
  Liver                                                        22.8                               34.0                                                                                         11.6    13.4   22.4    5.6
  Gallbladder^[b)](#tfn7-crt-2017-118){ref-type="table-fn"}^   7.7                                7.7                                                                                          7.7     4.1    5.1     3.4
  Pancreas                                                     10.1                               10.8                                                                                         9.3     5.6    7.1     4.4
  Larynx                                                       0.8                                1.5                                                                                          0.2     0.4    1.0     0.1
  Lung                                                         34.4                               50.4                                                                                         18.3    18.8   33.2    8.5
  Breast                                                       4.5                                0.1                                                                                          8.9     2.8    0.0     5.4
  Cervix uteri                                                 1.9                                \-                                                                                           3.8     1.1    \-      2.1
  Corpus uteri                                                 0.5                                \-                                                                                           1.0     0.3    \-      0.6
  Ovary                                                        2.0                                \-                                                                                           4.0     1.2    \-      2.3
  Prostate                                                     3.3                                6.6                                                                                          \-      1.6    4.5     \-
  Testis                                                       0.0                                0.1                                                                                          \-      0.0    0.0     \-
  Kidney                                                       1.9                                2.6                                                                                          1.1     1.0    1.8     0.5
  Bladder                                                      2.7                                4.0                                                                                          1.3     1.4    2.7     0.5
  Brain and CNS                                                2.5                                2.8                                                                                          2.2     1.7    2.1     1.4
  Thyroid                                                      0.7                                0.3                                                                                          1.0     0.4    0.2     0.4
  Hodgkin lymphoma                                             0.1                                0.1                                                                                          0.1     0.1    0.1     0.1
  Non-Hodgkin lymphoma                                         3.1                                3.6                                                                                          2.6     1.8    2.4     1.3
  Multiple myeloma                                             1.7                                1.9                                                                                          1.5     1.0    1.2     0.8
  Leukemia                                                     3.3                                3.6                                                                                          3.0     2.2    2.7     1.8
  Other and ill-defined                                        7.8                                8.3                                                                                          7.3     4.5    5.8     3.6

CNS, central nervous system.

Age-adjusted using the world standard population,

Includes the gallbladder and other/unspecified parts of the biliary tract.

###### 

Trends in cancer incidence rates from 1999 to 2014 in Korea

  Site/Type                                                    Both sexes   Men     Women                                                                                                                                                                                                                                                                                                                                                                                        
  ------------------------------------------------------------ ------------ ------- ----------- ------------------------------------------------------ ----------- ------------------------------------------------------- ------- ------- ----------- ------------------------------------------------------ ----------- ------------------------------------------------------- ------- ------- ----------- ------------------------------------------------------ ----------- -------------------------------------------------------
  All sites                                                    210.5        270.7   1999-2012   3.4^[a)](#tfn8-crt-2017-118){ref-type="table-fn"}^     2012-2014   --6.6^[a)](#tfn8-crt-2017-118){ref-type="table-fn"}^    285.0   302.2   1999-2011   1.7^[a)](#tfn8-crt-2017-118){ref-type="table-fn"}^     2011-2014   --3.6^[a)](#tfn8-crt-2017-118){ref-type="table-fn"}^    161.1   255.5   1999-2012   5.5^[a)](#tfn8-crt-2017-118){ref-type="table-fn"}^     2012-2014   --7.9^[a)](#tfn8-crt-2017-118){ref-type="table-fn"}^
  Lip, oral cavity, and pharynx                                3.6          4.0     1999-2014   0.5                                                    \-          \-                                                      6.1     6.1     1999-2014   --0.3                                                  \-          \-                                                      1.6     2.3     1999-2014   1.3^[a)](#tfn8-crt-2017-118){ref-type="table-fn"}^     \-          \-
  Esophagus                                                    4.1          2.8     1999-2014   --2.2^[a)](#tfn8-crt-2017-118){ref-type="table-fn"}^   \-          \-                                                      8.8     5.5     1999-2014   --2.7^[a)](#tfn8-crt-2017-118){ref-type="table-fn"}^   \-          \-                                                      0.6     0.4     1999-2014   --2.0^[a)](#tfn8-crt-2017-118){ref-type="table-fn"}^   \-          \-
  Stomach                                                      43.6         35.8    1999-2011   --0.1                                                  2011-2014   --5.8^[a)](#tfn8-crt-2017-118){ref-type="table-fn"}^    66.2    52.7    1999-2011   --0.3^[a)](#tfn8-crt-2017-118){ref-type="table-fn"}^   2011-2014   --6.3^[a)](#tfn8-crt-2017-118){ref-type="table-fn"}^    26.7    21.4    1999-2011   --0.3                                                  2011-2014   --5.4^[a)](#tfn8-crt-2017-118){ref-type="table-fn"}^
  Colon and rectum                                             20.4         31.9    1999-2010   6.0^[a)](#tfn8-crt-2017-118){ref-type="table-fn"}^     2010-2014   --4.6^[a)](#tfn8-crt-2017-118){ref-type="table-fn"}^    26.2    42.6    1999-2010   6.5^[a)](#tfn8-crt-2017-118){ref-type="table-fn"}^     2010-2014   --5.1^[a)](#tfn8-crt-2017-118){ref-type="table-fn"}^    16.4    23.0    1999-2009   5.3^[a)](#tfn8-crt-2017-118){ref-type="table-fn"}^     2009-2014   --2.5^[a)](#tfn8-crt-2017-118){ref-type="table-fn"}^
  Liver                                                        27.9         19.4    1999-2011   --1.7^[a)](#tfn8-crt-2017-118){ref-type="table-fn"}^   2011-2014   --5.2^[a)](#tfn8-crt-2017-118){ref-type="table-fn"}^    46.8    31.4    1999-2009   --1.8^[a)](#tfn8-crt-2017-118){ref-type="table-fn"}^   2009-2014   --3.8^[a)](#tfn8-crt-2017-118){ref-type="table-fn"}^    12.3    8.6     1999-2011   --1.4^[a)](#tfn8-crt-2017-118){ref-type="table-fn"}^   2011-2014   --6.1^[a)](#tfn8-crt-2017-118){ref-type="table-fn"}^
  Gallbladder^[b)](#tfn9-crt-2017-118){ref-type="table-fn"}^   6.5          6.2     1999-2005   1.1                                                    2005-2014   --1.2^[a)](#tfn8-crt-2017-118){ref-type="table-fn"}^    8.1     7.4     1999-2014   --0.6^[a)](#tfn8-crt-2017-118){ref-type="table-fn"}^   \-          \-                                                      5.3     5.2     1999-2003   2.7                                                    2003-2014   --1.2^[a)](#tfn8-crt-2017-118){ref-type="table-fn"}^
  Pancreas                                                     5.6          6.7     1999-2014   1.4^[a)](#tfn8-crt-2017-118){ref-type="table-fn"}^     \-          \-                                                      7.8     8.4     1999-2014   0.7^[a)](#tfn8-crt-2017-118){ref-type="table-fn"}^     \-          \-                                                      4.0     5.4     1999-2014   2.1^[a)](#tfn8-crt-2017-118){ref-type="table-fn"}^     \-          \-
  Larynx                                                       2.3          1.3     1999-2014   --3.6^[a)](#tfn8-crt-2017-118){ref-type="table-fn"}^   \-          \-                                                      4.9     2.7     1999-2014   --3.8^[a)](#tfn8-crt-2017-118){ref-type="table-fn"}^   \-          \-                                                      0.4     0.1     1999-2014   --7.1^[a)](#tfn8-crt-2017-118){ref-type="table-fn"}^   \-          \-
  Lung                                                         28.5         27.2    1999-2011   0.1                                                    2011-2014   --1.7^[a)](#tfn8-crt-2017-118){ref-type="table-fn"}^    51.4    43.7    1999-2005   --0.1                                                  2005-2014   --1.5^[a)](#tfn8-crt-2017-118){ref-type="table-fn"}^    12.4    14.9    1999-2011   1.9^[a)](#tfn8-crt-2017-118){ref-type="table-fn"}^     2011-2014   --0.4
  Breast                                                       10.7         24.0    1999-2005   7.6^[a)](#tfn8-crt-2017-118){ref-type="table-fn"}^     2005-2014   4.5^[a)](#tfn8-crt-2017-118){ref-type="table-fn"}^      0.2     0.2     1999-2014   --1.2                                                  \-          \-                                                      20.9    47.7    1999-2007   7.0^[a)](#tfn8-crt-2017-118){ref-type="table-fn"}^     2007-2014   4.2^[a)](#tfn8-crt-2017-118){ref-type="table-fn"}^
  Cervix uteri                                                 8.5          4.6     1999-2014   --4.1^[a)](#tfn8-crt-2017-118){ref-type="table-fn"}^   \-          \-                                                      \-      \-      \-          \-                                                     \-          \-                                                      16.3    9.0     1999-2014   --3.9^[a)](#tfn8-crt-2017-118){ref-type="table-fn"}^   \-          \-
  Corpus uteri                                                 1.4          2.9     1999-2009   6.2^[a)](#tfn8-crt-2017-118){ref-type="table-fn"}^     2009-2014   3.0^[a)](#tfn8-crt-2017-118){ref-type="table-fn"}^      \-      \-      \-          \-                                                     \-          \-                                                      2.8     5.7     1999-2009   6.4^[a)](#tfn8-crt-2017-118){ref-type="table-fn"}^     2009-2014   3.1^[a)](#tfn8-crt-2017-118){ref-type="table-fn"}^
  Ovary                                                        2.7          3.3     1999-2014   1.5^[a)](#tfn8-crt-2017-118){ref-type="table-fn"}^     \-          \-                                                      \-      \-      \-          \-                                                     \-          \-                                                      5.0     6.4     1999-2014   1.8^[a)](#tfn8-crt-2017-118){ref-type="table-fn"}^     \-          \-
  Prostate                                                     3.1          11.2    1999-2009   15.1^[a)](#tfn8-crt-2017-118){ref-type="table-fn"}^    2009-2014   0.6                                                     8.4     25.6    1999-2009   13.6^[a)](#tfn8-crt-2017-118){ref-type="table-fn"}^    2009-2014   --0.2                                                   \-      \-      \-          \-                                                     \-          \-
  Testis                                                       0.3          0.5     1999-2014   4.8^[a)](#tfn8-crt-2017-118){ref-type="table-fn"}^     \-          \-                                                      0.6     1.0     1999-2014   4.7^[a)](#tfn8-crt-2017-118){ref-type="table-fn"}^     \-          \-                                                      \-      \-      \-          \-                                                     \-          \-
  Kidney                                                       3.0          5.7     1999-2009   6.6^[a)](#tfn8-crt-2017-118){ref-type="table-fn"}^     2009-2014   1.6^[a)](#tfn8-crt-2017-118){ref-type="table-fn"}^      4.5     8.4     1999-2010   6.0^[a)](#tfn8-crt-2017-118){ref-type="table-fn"}^     2010-2014   0.7                                                     1.7     3.3     1999-2009   6.6^[a)](#tfn8-crt-2017-118){ref-type="table-fn"}^     2009-2014   0.9
  Bladder                                                      4.6          4.5     1999-2004   2.4^[a)](#tfn8-crt-2017-118){ref-type="table-fn"}^     2004-2014   --1.5^[a)](#tfn8-crt-2017-118){ref-type="table-fn"}^    9.0     8.4     1999-2005   1.5^[a)](#tfn8-crt-2017-118){ref-type="table-fn"}^     2005-2014   --1.9^[a)](#tfn8-crt-2017-118){ref-type="table-fn"}^    1.6     1.5     1999-2003   2.9                                                    2003-2014   --2.0^[a)](#tfn8-crt-2017-118){ref-type="table-fn"}^
  Brain and CNS                                                2.9          2.7     1999-2009   1.1^[a)](#tfn8-crt-2017-118){ref-type="table-fn"}^     2009-2014   --2.4                                                   3.2     3.0     1999-2009   1.3^[a)](#tfn8-crt-2017-118){ref-type="table-fn"}^     2009-2014   --2.5                                                   2.6     2.4     1999-2007   1.5^[a)](#tfn8-crt-2017-118){ref-type="table-fn"}^     2007-2014   --1.7
  Thyroid                                                      6.3          43.3    1999-2011   22.4^[a)](#tfn8-crt-2017-118){ref-type="table-fn"}^    2011-2014   --10.8^[a)](#tfn8-crt-2017-118){ref-type="table-fn"}^   2.1     17.3    1999-2012   22.8^[a)](#tfn8-crt-2017-118){ref-type="table-fn"}^    2012-2014   --16.7^[a)](#tfn8-crt-2017-118){ref-type="table-fn"}^   10.4    69.8    1999-2011   22.1^[a)](#tfn8-crt-2017-118){ref-type="table-fn"}^    2011-2014   --11.9^[a)](#tfn8-crt-2017-118){ref-type="table-fn"}^
  Hodgkin lymphoma                                             0.2          0.5     1999-2014   4.4^[a)](#tfn8-crt-2017-118){ref-type="table-fn"}^     \-          \-                                                      0.4     0.5     1999-2014   3.5^[a)](#tfn8-crt-2017-118){ref-type="table-fn"}^     \-          \-                                                      0.1     0.4     1999-2014   5.5^[a)](#tfn8-crt-2017-118){ref-type="table-fn"}^     \-          \-
  Non-Hodgkin lymphoma                                         4.5          6.8     1999-2014   3.4^[a)](#tfn8-crt-2017-118){ref-type="table-fn"}^     \-          \-                                                      5.8     8.1     1999-2014   2.7^[a)](#tfn8-crt-2017-118){ref-type="table-fn"}^     \-          \-                                                      3.4     5.7     1999-2011   4.7^[a)](#tfn8-crt-2017-118){ref-type="table-fn"}^     2011-2014   1.0
  Multiple myeloma                                             1.0          1.6     1999-2014   3.5^[a)](#tfn8-crt-2017-118){ref-type="table-fn"}^     \-          \-                                                      1.2     2.0     1999-2014   3.2^[a)](#tfn8-crt-2017-118){ref-type="table-fn"}^     \-          \-                                                      0.8     1.3     1999-2014   3.7^[a)](#tfn8-crt-2017-118){ref-type="table-fn"}^     \-          \-
  Leukemia                                                     4.7          5.2     1999-2014   0.9^[a)](#tfn8-crt-2017-118){ref-type="table-fn"}^     \-          \-                                                      5.5     6.1     1999-2014   0.9^[a)](#tfn8-crt-2017-118){ref-type="table-fn"}^     \-          \-                                                      3.9     4.3     1999-2014   0.6^[a)](#tfn8-crt-2017-118){ref-type="table-fn"}^     \-          \-
  Other and ill-defined                                        14.3         18.6    1999-2014   2.2^[a)](#tfn8-crt-2017-118){ref-type="table-fn"}^     \-          \-                                                      17.9    21.0    1999-2014   1.6^[a)](#tfn8-crt-2017-118){ref-type="table-fn"}^     \-          \-                                                      11.8    16.6    1999-2010   3.2^[a)](#tfn8-crt-2017-118){ref-type="table-fn"}^     2010-2014   0.7

APC was calculated using age-standardized incidence data based on the Segi's world standard population. APC, annual percentage change; CNS, central nervous system.

Significantly different from zero (p \< 0.05),

Includes the gallbladder and other/unspecified parts of the biliary tract.

###### 

Trends in cancer mortality rates from 1999 to 2014 in Korea

  Site/Type                                                     Both sexes   Men    Women                                                                                                                                                                                                                                                                                                                                                                                          
  ------------------------------------------------------------- ------------ ------ ----------- ------------------------------------------------------- ----------- ------------------------------------------------------- ------- ------- ----------- ------------------------------------------------------- ----------- ------------------------------------------------------- ------ ------ ----------- -------------------------------------------------------- ----------- -------------------------------------------------------
  All sites                                                     114.3        85.1   1999-2002   1.0                                                     2002-2014   --2.7^[a)](#tfn10-crt-2017-118){ref-type="table-fn"}^   176.6   125.8   1999-2002   1.1                                                     2002-2014   --3.1^[a)](#tfn10-crt-2017-118){ref-type="table-fn"}^   70.6   55.6   1999-2002   1.0                                                      2002-2014   --2.2^[a)](#tfn10-crt-2017-118){ref-type="table-fn"}^
  Lip, oral cavity, and pharynx                                 1.1          1.3    1999-2014   --2.0^[a)](#tfn10-crt-2017-118){ref-type="table-fn"}^   \-          \-                                                      2.0     2.1     1999-2014   --2.2^[a)](#tfn10-crt-2017-118){ref-type="table-fn"}^   \-          \-                                                      0.4    0.5    1999-2014   --3.1^[a)](#tfn10-crt-2017-118){ref-type="table-fn"}^    \-          \-
  Esophagus                                                     3.1          1.7    1999-2014   --4.5^[a)](#tfn10-crt-2017-118){ref-type="table-fn"}^   \-          \-                                                      6.8     3.6     1999-2014   --4.7^[a)](#tfn10-crt-2017-118){ref-type="table-fn"}^   \-          \-                                                      0.5    0.2    1999-2014   --5.2^[a)](#tfn10-crt-2017-118){ref-type="table-fn"}^    \-          \-
  Stomach                                                       23.8         9.7    1999-2003   --3.3^[a)](#tfn10-crt-2017-118){ref-type="table-fn"}^   2003-2014   --6.6^[a)](#tfn10-crt-2017-118){ref-type="table-fn"}^   36.9    15.1    1999-2002   --1.3                                                   2002-2014   --6.7^[a)](#tfn10-crt-2017-118){ref-type="table-fn"}^   14.6   5.7    1999-2003   --4.4^[a)](#tfn10-crt-2017-118){ref-type="table-fn"}^    2003-2014   --6.6^[a)](#tfn10-crt-2017-118){ref-type="table-fn"}^
  Colon and rectum                                              7.7          9.0    1999-2004   5.2^[a)](#tfn10-crt-2017-118){ref-type="table-fn"}^     2004-2014   --1.0^[a)](#tfn10-crt-2017-118){ref-type="table-fn"}^   10.5    12.6    1999-2004   5.6^[a)](#tfn10-crt-2017-118){ref-type="table-fn"}^     2004-2014   --0.7^[a)](#tfn10-crt-2017-118){ref-type="table-fn"}^   6.0    6.3    1999-2004   4.7^[a)](#tfn10-crt-2017-118){ref-type="table-fn"}^      2004-2014   --1.7^[a)](#tfn10-crt-2017-118){ref-type="table-fn"}^
  Liver                                                         20.4         13.4   1999-2002   0.7                                                     2002-2014   --3.6^[a)](#tfn10-crt-2017-118){ref-type="table-fn"}^   35.3    22.4    1999-2002   --0.2                                                   2002-2014   --3.7^[a)](#tfn10-crt-2017-118){ref-type="table-fn"}^   8.3    5.6    1999-2002   2.9^[a)](#tfn10-crt-2017-118){ref-type="table-fn"}^      2002-2014   --3.7^[a)](#tfn10-crt-2017-118){ref-type="table-fn"}^
  Gallbladder^[b)](#tfn11-crt-2017-118){ref-type="table-fn"}^   5.2          4.1    1999-2001   7.7                                                     2001-2014   --2.8^[a)](#tfn10-crt-2017-118){ref-type="table-fn"}^   6.8     5.1     1999-2001   6.7                                                     2001-2014   --3.0^[a)](#tfn10-crt-2017-118){ref-type="table-fn"}^   4.1    3.4    1999-2001   9.3                                                      2001-2014   --2.7^[a)](#tfn10-crt-2017-118){ref-type="table-fn"}^
  Pancreas                                                      5.4          5.6    1999-2014   0.3^[a)](#tfn10-crt-2017-118){ref-type="table-fn"}^     \-          \-                                                      7.6     7.1     1999-2014   --0.4^[a)](#tfn10-crt-2017-118){ref-type="table-fn"}^   \-          \-                                                      3.9    4.4    1999-2014   0.8^[a)](#tfn10-crt-2017-118){ref-type="table-fn"}^      \-          \-
  Larynx                                                        1.6          0.4    1999-2014   --9.6^[a)](#tfn10-crt-2017-118){ref-type="table-fn"}^   \-          \-                                                      3.4     1.0     1999-2014   --9.1^[a)](#tfn10-crt-2017-118){ref-type="table-fn"}^   \-          \-                                                      0.4    0.1    1999-2012   --15.3^[a)](#tfn10-crt-2017-118){ref-type="table-fn"}^   2012-2014   16.4
  Lung                                                          22.4         18.8   1999-2001   3.7^[a)](#tfn10-crt-2017-118){ref-type="table-fn"}^     2001-2014   --1.9^[a)](#tfn10-crt-2017-118){ref-type="table-fn"}^   41.5    33.2    1999-2001   4.0                                                     2001-2014   --2.4^[a)](#tfn10-crt-2017-118){ref-type="table-fn"}^   9.4    8.5    1999-2001   4.2                                                      2001-2014   --1.4^[a)](#tfn10-crt-2017-118){ref-type="table-fn"}^
  Breast                                                        2.2          2.8    1999-2014   1.4^[a)](#tfn10-crt-2017-118){ref-type="table-fn"}^     \-          \-                                                      0.1     0.0     1999-2014   --4.6^[a)](#tfn10-crt-2017-118){ref-type="table-fn"}^   \-          \-                                                      4.2    5.4    1999-2014   1.7^[a)](#tfn10-crt-2017-118){ref-type="table-fn"}^      \-          \-
  Cervix uteri                                                  1.4          1.1    1999-2003   8.8^[a)](#tfn10-crt-2017-118){ref-type="table-fn"}^     2003-2014   --5.5^[a)](#tfn10-crt-2017-118){ref-type="table-fn"}^   \-      \-      \-          \-                                                      \-          \-                                                      2.6    2.1    1999-2003   8.2^[a)](#tfn10-crt-2017-118){ref-type="table-fn"}^      2003-2014   --5.2^[a)](#tfn10-crt-2017-118){ref-type="table-fn"}^
  Corpus uteri                                                  0.1          0.3    1999-2003   35.7^[a)](#tfn10-crt-2017-118){ref-type="table-fn"}^    2003-2014   2.4^[a)](#tfn10-crt-2017-118){ref-type="table-fn"}^     \-      \-      \-          \-                                                      \-          \-                                                      0.1    0.6    1999-2003   35.7^[a)](#tfn10-crt-2017-118){ref-type="table-fn"}^     2003-2014   2.8^[a)](#tfn10-crt-2017-118){ref-type="table-fn"}^
  Ovary                                                         0.9          1.2    1999-2001   10.6                                                    2001-2014   0.3                                                     \-      \-      \-          \-                                                      \-          \-                                                      1.7    2.3    1999-2014   1.1^[a)](#tfn10-crt-2017-118){ref-type="table-fn"}^      \-          \-
  Prostate                                                      0.9          1.6    1999-2002   16.1^[a)](#tfn10-crt-2017-118){ref-type="table-fn"}^    2002-2014   1.2^[a)](#tfn10-crt-2017-118){ref-type="table-fn"}^     2.6     4.5     1999-2002   16.7^[a)](#tfn10-crt-2017-118){ref-type="table-fn"}^    2002-2014   0.7^[a)](#tfn10-crt-2017-118){ref-type="table-fn"}^     \-     \-     \-          \-                                                       \-          \-
  Testis                                                        0.0          0.0    1999-2014   --2.3                                                   \-          \-                                                      0.1     0.0     1999-2014   --2.5                                                   \-          \-                                                      \-     \-     \-          \-                                                       \-          \-
  Kidney                                                        1.1          1.0    1999-2014   0.0                                                     \-          \-                                                      1.8     1.8     1999-2014   0.2                                                     \-          \-                                                      0.5    0.5    1999-2014   --0.8                                                    \-          \-
  Bladder                                                       1.3          1.4    1999-2014   --1.2^[a)](#tfn10-crt-2017-118){ref-type="table-fn"}^   \-          \-                                                      2.6     2.7     1999-2014   --1.4^[a)](#tfn10-crt-2017-118){ref-type="table-fn"}^   \-          \-                                                      0.5    0.5    1999-2001   11.1                                                     2001-2014   --2.0^[a)](#tfn10-crt-2017-118){ref-type="table-fn"}^
  Brain and CNS                                                 1.9          1.7    1999-2002   4.6                                                     2002-2014   --2.1^[a)](#tfn10-crt-2017-118){ref-type="table-fn"}^   2.2     2.1     1999-2014   --1.5^[a)](#tfn10-crt-2017-118){ref-type="table-fn"}^   \-          \-                                                      1.6    1.4    1999-2014   --1.5^[a)](#tfn10-crt-2017-118){ref-type="table-fn"}^    \-          \-
  Thyroid                                                       0.4          0.4    1999-2003   6.7                                                     2003-2014   --3.9^[a)](#tfn10-crt-2017-118){ref-type="table-fn"}^   0.3     0.2     1999-2002   15.4                                                    2002-2014   --3.7^[a)](#tfn10-crt-2017-118){ref-type="table-fn"}^   0.5    0.4    1999-2004   4.1                                                      2004-2014   --4.5^[a)](#tfn10-crt-2017-118){ref-type="table-fn"}^
  Hodgkin lymphoma                                              0.0          0.1    1999-2003   27.8^[a)](#tfn10-crt-2017-118){ref-type="table-fn"}^    2003-2014   0.8                                                     0.0     0.1     1999-2004   18.2^[a)](#tfn10-crt-2017-118){ref-type="table-fn"}^    2004-2014   --1.2^[a)](#tfn10-crt-2017-118){ref-type="table-fn"}^   0.0    0.1    1999-2002   56.3                                                     2002-2014   3.5^[a)](#tfn10-crt-2017-118){ref-type="table-fn"}^
  Non-Hodgkin lymphoma                                          2.1          1.8    1999-2014   --0.9^[a)](#tfn10-crt-2017-118){ref-type="table-fn"}^   \-          \-                                                      3.0     2.4     1999-2014   --1.2                                                   \-          \-                                                      1.4    1.3    1999-2014   --0.5                                                    \-          \-
  Multiple myeloma                                              0.6          1.0    1999-2003   12.6^[a)](#tfn10-crt-2017-118){ref-type="table-fn"}^    2003-2014   1.0                                                     0.8     1.2     1999-2002   14.3^[a)](#tfn10-crt-2017-118){ref-type="table-fn"}^    2002-2014   1.4^[a)](#tfn10-crt-2017-118){ref-type="table-fn"}^     0.4    0.8    1999-2007   7.6^[a)](#tfn10-crt-2017-118){ref-type="table-fn"}^      2007-2014   --1.6
  Leukemia                                                      2.9          2.2    1999-2001   1.4                                                     2001-2014   --2.0^[a)](#tfn10-crt-2017-118){ref-type="table-fn"}^   3.5     2.7     1999-2014   --1.7^[a)](#tfn10-crt-2017-118){ref-type="table-fn"}^   \-          \-                                                      2.4    1.8    1999-2014   --2.0^[a)](#tfn10-crt-2017-118){ref-type="table-fn"}^    \-          \-
  Other and ill-defined                                         7.8          4.5    1999-2014   --3.0^[a)](#tfn10-crt-2017-118){ref-type="table-fn"}^   \-          \-                                                      9.0     5.8     1999-2009   --0.5                                                   2009-2014   --7.2^[a)](#tfn10-crt-2017-118){ref-type="table-fn"}^   7.0    3.6    1999-2005   --7.1^[a)](#tfn10-crt-2017-118){ref-type="table-fn"}^    2005-2014   --1.9^[a)](#tfn10-crt-2017-118){ref-type="table-fn"}^

APC was calculated using age-standardized incidence data based on the Segi's world standard population. APC, annual percentage change; CNS, central nervous system.

Significantly different from zero (p \< 0.05),

Includes the gallbladder and other/unspecified parts of the biliary tract.

###### 

The five common sites of cancer incidence by age group and sex in Korea, 2014

  Rank        Age (yr)                                                                            
  ----------- ---------------------------- ---------------------------- ------------------------- --------------------------
  **Men**                                                                                         
   1          Leukemia (4.4)               Thyroid (13.5)               Stomach (86.7)            Lung (445.7)
   2          Non-Hodgkin lymphoma (2.8)   Non-Hodgkin lymphoma (3.2)   Colon and rectum (66.0)   Stomach (373.6)
   3          Brain and CNS (1.8)          Colon and rectum (3.1)       Liver (59.1)              Colon and rectum (313.5)
   4          Liver (0.4)                  Leukemia (3.1)               Lung (42.8)               Prostate (284.2)
   5          Testis (0.3)                 Testis (2.1)                 Thyroid (38.8)            Liver (192.4)
  **Women**                                                                                       
   1          Leukemia (4.1)               Thyroid (54.7)               Thyroid (161.4)           Colon and rectum (168.5)
   2          Non-Hodgkin lymphoma (2.0)   Breast (11.4)                Breast (129.0)            Stomach (142.2)
   3          Brain and CNS (1.7)          Cervix uteri (5.3)           Colon and rectum (38.7)   Lung (126.8)
   4          Ovary (0.8)                  Ovary (3.3)                  Stomach (37.6)            Breast (73.5)
   5          Thyroid (0.6)                Stomach (3.3)                Lung (22.2)               Liver (71.7)

CNS, central nervous system.

###### 

Trends in the 5-year relative survival rates (%) by year of diagnosis from 1993 to 2014 in Korea

  Site/Type                                                     Both sexes   Men    Women                                                                                   
  ------------------------------------------------------------- ------------ ------ ------- ------- ------ ------ ------ ------ ------- ------ ------ ------ ------ ------- ------
  All sites                                                     41.2         44.0   53.9    70.3    29.1   31.7   35.3   45.3   62.2    30.5   53.4   55.3   64.0   78.2    24.8
  Lip, oral cavity, and pharynx                                 41.1         46.7   54.2    63.5    22.4   35.8   41.1   49.4   59.8    24.0   58.1   63.8   67.8   72.4    14.3
  Esophagus                                                     12.7         15.2   21.2    35.0    22.3   11.8   14.3   20.5   34.7    22.9   23.7   24.2   29.6   37.3    13.6
  Stomach                                                       42.8         46.6   57.7    74.4    31.6   43.0   46.9   58.4   75.3    32.3   42.6   46.0   56.4   72.7    30.1
  Colon and rectum                                              54.8         58.0   66.6    76.3    21.5   55.3   59.0   68.5   78.1    22.8   54.2   56.8   64.2   73.4    19.2
  Liver                                                         10.7         13.2   20.2    32.8    22.1   9.9    12.9   20.2   33.1    23.2   13.6   14.2   20.5   31.9    18.3
  Gallbladder^[b)](#tfn13-crt-2017-118){ref-type="table-fn"}^   17.3         19.7   22.8    29.2    11.9   16.6   20.3   23.4   30.1    13.5   18.0   19.1   22.4   28.4    10.4
  Pancreas                                                      9.4          7.6    8.2     10.1    0.7    8.8    7.3    8.2    9.8     1.0    10.1   8.1    8.2    10.5    0.4
  Larynx                                                        59.7         62.3   66.2    74.6    14.9   60.2   62.8   66.8   74.9    14.7   55.4   57.8   58.2   70.7    15.3
  Lung                                                          11.3         12.7   16.2    25.1    13.8   10.4   11.6   15.0   21.9    11.5   14.2   16.2   19.7   32.4    18.2
  Breast                                                        77.9         83.2   88.5    92.0    14.1   75.1   85.6   87.1   86.8    11.7   78.0   83.2   88.5   92.0    14.0
  Cervix uteri                                                  77.5         80.0   81.3    79.7    2.2    \-     \-     \-     \-      \-     77.5   80.0   81.3   79.7    2.2
  Corpus uteri                                                  81.5         81.8   84.6    87.9    6.4    \-     \-     \-     \-      \-     81.5   81.8   84.6   87.9    6.4
  Ovary                                                         58.7         58.9   61.5    64.1    5.4    \-     \-     \-     \-      \-     58.7   58.9   61.5   64.1    5.4
  Prostate                                                      55.9         67.2   80.3    93.3    37.4   55.9   67.2   80.3   93.3    37.4   \-     \-     \-     \-      \-
  Testis                                                        85.4         90.4   90.6    96.0    10.6   85.4   90.4   90.6   96.0    10.6   \-     \-     \-     \-      \-
  Kidney                                                        62.0         66.1   73.4    81.3    19.3   60.8   64.4   72.8   80.8    20.0   64.5   69.7   74.5   82.5    18.0
  Bladder                                                       69.1         73.1   75.6    75.6    6.5    70.0   74.8   77.4   77.5    7.5    65.5   66.3   68.6   67.9    2.4
  Brain and CNS                                                 38.5         39.0   40.8    40.8    2.3    37.2   37.5   40.2   39.4    2.2    40.2   40.7   41.5   42.4    2.2
  Thyroid                                                       94.2         94.9   98.3    100.2   6.0    87.2   89.5   95.8   100.5   13.3   95.4   95.9   98.7   100.1   4.7
  Hodgkin lymphoma                                              68.0         71.2   76.7    80.6    12.6   67.6   68.1   74.7   81.6    14.0   68.6   77.4   80.7   78.8    10.2
  Non-Hodgkin lymphoma                                          46.6         50.8   59.9    69.1    22.5   45.3   48.9   58.1   67.4    22.1   48.7   53.5   62.4   71.1    22.4
  Multiple myeloma                                              22.1         19.8   29.3    40.1    18.0   21.1   17.8   29.6   39.7    18.6   23.3   22.1   29.1   40.6    17.3
  Leukemia                                                      26.5         33.3   41.8    51.1    24.6   26.2   32.3   41.7   50.9    24.7   26.8   34.6   42.0   51.4    24.6
  Other and ill-defined                                         42.1         45.9   56.0    69.1    27.0   37.4   42.4   52.3   65.7    28.3   47.4   50.0   60.0   72.6    25.2

CNS, central nervous system.

Percentage change in 5-year relative survival from 1993 to 1995 and 2010 to 2014,

Includes the gallbladder and other/unspecified parts of the biliary tract.

###### 

Crude and age-standardized rates of cancer prevalence by sex on January 1, 2015 in Korea

  Site/Type                                                     Crude prevalence rate per 100,000^[a)](#tfn14-crt-2017-118){ref-type="table-fn"}^   Age-standardized prevalence rate per 100,000^[b)](#tfn15-crt-2017-118){ref-type="table-fn"}^                                 
  ------------------------------------------------------------- ----------------------------------------------------------------------------------- ---------------------------------------------------------------------------------------------- --------- --------- --------- ---------
  All sites                                                     2,885.8                                                                             2,543.2                                                                                        3,228.2   1,837.6   1,730.9   2,027.1
  Lip, oral cavity, and pharynx                                 38.8                                                                                52.2                                                                                           25.3      25.0      35.5      15.8
  Esophagus                                                     16.7                                                                                30.2                                                                                           3.3       9.9       20.0      1.7
  Stomach                                                       463.3                                                                               615.8                                                                                          310.8     278.1     407.6     171.5
  Colon and rectum                                              398.5                                                                               477.1                                                                                          320.0     237.5     317.6     173.1
  Liver                                                         113.6                                                                               170.2                                                                                          57.1      71.8      114.2     33.5
  Gallbladder^[c)](#tfn16-crt-2017-118){ref-type="table-fn"}^   33.6                                                                                34.5                                                                                           32.7      19.4      22.8      16.8
  Pancreas                                                      16.7                                                                                17.9                                                                                           15.5      10.2      12.1      8.7
  Larynx                                                        18.2                                                                                34.3                                                                                           2.2       10.8      22.8      1.1
  Lung                                                          125.0                                                                               158.0                                                                                          92.0      74.5      105.0     51.0
  Breast                                                        313.1                                                                               2.5                                                                                            623.5     201.8     1.6       396.8
  Cervix uteri                                                  89.0                                                                                \-                                                                                             178.0     56.7      \-        110.5
  Corpus uteri                                                  36.2                                                                                \-                                                                                             72.4      23.7      \-        46.5
  Ovary                                                         31.8                                                                                \-                                                                                             63.7      22.2      \-        44.0
  Prostate                                                      122.6                                                                               245.3                                                                                          \-        67.1      160.7     \-
  Testis                                                        5.1                                                                                 10.1                                                                                           \-        4.6       9.0       \-
  Kidney                                                        62.3                                                                                84.4                                                                                           40.2      40.2      57.5      24.9
  Bladder                                                       56.3                                                                                91.8                                                                                           20.7      32.1      61.2      10.1
  Brain and CNS                                                 18.7                                                                                19.3                                                                                           18.1      16.1      17.0      15.0
  Thyroid                                                       646.3                                                                               215.6                                                                                          1076.8    438.4     148.2     726.7
  Hodgkin lymphoma                                              4.6                                                                                 5.8                                                                                            3.3       3.8       4.8       2.9
  Non-Hodgkin lymphoma                                          62.2                                                                                66.9                                                                                           57.4      44.1      50.1      38.7
  Multiple myeloma                                              9.5                                                                                 9.9                                                                                            9.1       5.8       6.6       5.1
  Leukemia                                                      33.8                                                                                37.6                                                                                           30.0      31.7      35.6      28.0
  Other and ill-defined                                         170.0                                                                               163.8                                                                                          176.2     112.0     120.7     104.7

CNS, central nervous system.

Crude prevalence rate: number of prevalent cases divided by the corresponding person-years of observation. Prevalent cases were defined as patients who were diagnosed between January 1, 1999 and December 31, 2014 and who were alive on January 1, 2015. Multiple primary cancer cases were counted multiple times,

Age-adjusted using the Segi's world standard population,

Includes the gallbladder and other/unspecified parts of the biliary tract.

[^1]: Chang-Hoon Kim (Busan Cancer Registry, Pusan National University Hospital), Cheol-In Yoo (Ulsan Caner Registry, Ulsan University Hospital), Heon Kim (Chungbuk Cancer Registry, Chungbuk National University Hospital), Hae-Sung Nam (Daejeon/Chungnam Cancer Registry, Chungnam National University and Hospital), Jung-Sik Huh (Jeju Cancer Registry, Jeju National University and Hospital), Jung-Ho Youm (Chonbuk Cancer Registry, Chonbuk National University Hospital), Moo-Kyung Oh (Kangwon Cancer Registry, Kangwon National University Hospital), Nam-Soo Hong (Deagu/Gyeongbuk Cancer Registry, Kyungpook National University Medical Center), Sun-Seog Kweon (Gwangju/Jeonnam Cancer Registry, Chonnam National University Hwasun Hospital), Woo-Chul Kim (Incheon Cancer Registry, Inha University Hospital), Yune-Sik Kang (Gyeongnam Cancer Registry, Gyeongsang National University and Hospital)
